Heavyweights such as KKR, PepsiCo, Nestle and Danone are among the companies rumoured to be in early-stage talks to acquire GlaxoSmithKline's (GSK) 72% stake in its Indian consumer products division. The $4bn deal for a majority slice of GSK Consumer Healthcare in India is thought to be the biggest in the sector in India's history. Formal, non-binding bids are expected to be submitted in June, after which a shortlist of contenders will go through a second round of negotiations, according to a source. GSK aims to use the funds raised from the sale to buy out Novartis from a joint venture.
Heavyweights such as KKR, Nestle, PepsiCo and Danone are among the companies rumoured to be in early-stage talks to acquire GlaxoSmithKline's (GSK) 72% stake in its Indian consumer products division. The $4bn deal for a majority slice of GSK Consumer Healthcare in India is thought to be the biggest in the sector in India's history. Formal, non-binding bids are expected to be submitted in June, after which a shortlist of contenders will go through a second round of negotiations, according to a source. GSK aims to use the funds raised from the sale to buy out Novartis from a joint venture.